English Français AddMedica ADDMEDICA Business Opportunities Range of Products Meet ADDMEDICA 1 2 3 ADDMEDICA is actively engaged against sickle cell disease. Sickle Cell disease (SCD) is a genetic disease affecting red blood cells. Sickle-cell disease (SCD), or sickle-cell anaemia (SCA) or drepanocytosis, is an autosomal recessive genetic blood disorder characterized by red blood cells that assume an abnormal, rigid, sickle shape. Sickling decreases the cells' flexibility and results in a risk of various complications. The part of the website dedicated to the information of physicians and medical staff is opening very soon. Chairman's foreword Welcome to the ADDMEDICA Internet website. > Read more Business opportunities ADDMEDICA: a partner to develop and distribute medical products with high medical added value in Europe. > Read more Hematology Sickle Cell disease (SCD) is a genetic disease affecting red blood cells. > Read more Information & Contacts > Read more Wound healing > Read more Legal information Contact Career Sitemap ADDMEDICA Chairman's foreword Mission Executive Committee History Information & Contacts Business Opportunities Partners Range of Products Hematology Wound Healing Meet ADDMEDICA Last update date: 07/09/2017

English Français AddMedica ADDMEDICA Business Opportunities Range of Products Meet ADDMEDICA Print Legal Information © 2010 addmedica Tous droits réservés All rights reserved Legal information Contact Career Sitemap ADDMEDICA Chairman's foreword Mission Executive Committee History Information & Contacts Business Opportunities Partners Range of Products Hematology Wound Healing Meet ADDMEDICA Last update date: 22/08/2017

English Français AddMedica ADDMEDICA Business Opportunities Range of Products Meet ADDMEDICA ADDMEDICA Chairman's foreword Mission Executive Committee History Information & Contacts Home > ADDMEDICA > Chairman's foreword Print Chairman's foreword Welcome to the ADDMEDICA Internet website. Since its foundation in 2005, ADDMEDICA has constantly developed with focus on patients suffering from rare diseases or severe clinical conditions. In hematology, the company holds the European Marketing Approval of the sole drug indicated in a rare disease called Sickle Cell Disease. In the domain of organ grafts, it distributed in France the best fitted preservation solution for pulmonary grafts, as well as an experimental solution designed to assess the functionality of the lung before transplantation. Lastly, in the domain of wound healing, it commercializes a range of high technology products, mainly for hospital use. Some new products are soon expected to complete this range, always oriented towards unmet medical needs. Proud of the past accomplishments, all ADDMEDICA team, motivated by its useful mission, is entering the coming years with confidence in its success. François ANGER Chairman Last update date: 27/07/2016 Legal information Contact Career Sitemap ADDMEDICA Chairman's foreword Mission Executive Committee History Information & Contacts Business Opportunities Partners Range of Products Hematology Wound Healing Meet ADDMEDICA Last update date: 22/08/2017